Bluebird bio Inc (NASDAQ:BLUE) has a beta value of 0.82 and has seen 4.92 million shares traded in the last trading session. The company, currently valued at $187.98M, closed the last trade at $0.98 per share which meant it -0.90% during that session. The BLUE stock price is -464.29% off its 52-week high price of $5.53 and 13.27% above the 52-week low of $0.85. The 3-month trading volume is 6.15 million shares.
Bluebird bio Inc (NASDAQ:BLUE) trade information
Sporting -0.90% in the red in last session, the stock has traded in the red over the last five days, when the BLUE stock price touched $0.98 or saw a rise of 2.97%. Year-to-date, Bluebird bio Inc shares have moved -29.33%, while the 5-day performance has seen it change -4.38%. Over the past 30 days, the shares of Bluebird bio Inc (NASDAQ:BLUE) have changed 8.90%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Bluebird bio Inc (BLUE) estimates and forecasts
The company’s shares have lost -30.83% over the past 6 months, compared to 15.50% for the industry.
Earnings growth for 2024 is a modest 6.39% while over the next 5 years, the company’s earnings are expected to increase by 45.80%.
BLUE Dividends
Bluebird bio Inc is expected to release its next earnings report in August this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
